Q4 2025 Earnings Call March 10, 2026 Disclaimer This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and 21E of the Securities Exchange Act of 1934, as amended, which provides a "safe harbor" for such statements in certain circumstances. When used in this presentation, the words "anticipates," "may," "believes," "expects," "intends," "plans," "estimates," "predicts," the negative expressions of such words, or similar expressions a ...

Patient Focused. Discovery Driven. Accelerating personalized medicine in autoimmune disease Q4 & FY 2025 UPD ATE | MARCH 10, 20 26 Disclaimer 2 Identifying autoimmune disease is a challenge… Ambiguous symptoms Manifestations overlap Tests lack specificity, sensitivity Outdated tech, testing delays High rate of misdiagnosis With rheumatoid arthritis2 ~1M Americans diagnosed with lupus1 ~2M >41M A M E R I C A N S A N A + ANA+: antinuclear antibody positive, first-line screen for autoimmune disease 3 3 1. lupu ...

Fourth Quarter and Full Year 2025 Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statements. Such risk factors include, but are not limited to, the following: Investors should carefully consider these risk factors, other risk factors described herein, and the additional risk factors outlined in more detail in our 2024 Form 10-K, filed with the Securities and Exchang ...

© 2026 TransUnion, its subsidiaries and/or affiliates. All Rights Reserved. 1 Forward-Looking Statements Non-GAAP Financial Information This investor presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the current beliefs and expectations of TransUnion's management and are subject to significant risks and uncertainties. Actual results may differ materially from those described in the forward-looking statem ...

2026 Investor Day Empowering Consumers with a Scalable Ecosystem March 10 | New York City 2026 INVESTOR DAY 1 Welcome and Opening Remarks John A. Baugh, CFA VP, Investor Relations 2026 INVESTOR DAY 2 Forward Looking Statements Statements in this presentation regarding PROG Holdings, Inc.'s (the "Company") businesses, operations and performance that are not historical facts are "forward-looking statements" that involve risks and uncertainties which could cause actual results to differ materially from those c ...

BILBAO - 10 MARCH 2026 FROM MEGA TO GIGA CAPITAL MARKETS DAY 2026 BILBAO - 10 MARCH 2026 FROM MEGA TO GIGA CAPITAL MARKETS DAY 2026 1. THE DATA CENTERS OPPORTUNITY 2. MERLIN: THE NAME OF THE GAME 3. PHASE III: FROM MEGA TO GIGA 4. FUTURE PIPELINE ZOOM-IN 1. THE DATA CENTERS OPPORTUNITY The data centers opportunity | Exponential growth in global demand BY 2030, 70% OF THE DEMAND FOR DATA CENTER CAPACITY WILL BE FOR ADVANCED-AI WORKLOADS Gigawatts 44 38 2025 62 40 2026 83 45 2027 102 50 2028 124 56 2029 156 6 ...

Corporate Presentation March 2026 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended (the "Act"). Forward-looking statements are statements that are not of historical fact and include, without limitation, statements regarding future events, our future financial condition, results of operations, business strategy and plans, prospective products (as well as their potential to achieve a differ ...

Q4 and Full Year 2025 Earnings Presentation March 10, 2026 © 2026 Esperion Therapeutics, Inc. All rights reserved. Forward-looking Statements & Disclosures This investor presentation contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws, including statements regarding marketing strategy and commercialization and business development plans, current and planned operational expenses, expected profitability, future operations, commercial products ...

Howmet Aerospace Technology & Markets Day 2026 March 10, 2026 Important Information Forward–Looking Statements This presentation contains statements that relate to future events and expectations and as such constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include those containing such words as "anticipates", "believes", "could", "envisions", "estimates", "expects", "forecasts", "goal", "guidance", "intends", "may", " ...

March 10, 2026 Fourth Quarter and Full Year 2025 Financial Results & Corporate Update This presentation is for investor relations purposes only - Not for product promotional purposes 1 Agenda | 1 | Opening Remarks | | --- | --- | | 2 | Q4 2025 Highlights & Recent Accomplishments | | 3 | ASH & Tandem Summary | | 4 | Pipeline | | 5 | CARVYKTI® Performance Overview | | 6 | Financial Performance | | 7 | Q&A | 2 This presentation is for investor relations purposes only - Not for product promotional purposes Ying ...